SRx Health Solutions (SRXH) Cash from Financing Activities (2010 - 2025)

SRx Health Solutions has reported Cash from Financing Activities for 16 years, with the latest figure at $3.2 million in Q2 2025.

• For the quarter ending Q2 2025, Cash from Financing Activities fell 17.89% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2025 stood at $3.5 million (down 6.88% YoY), and the FY2025 full-year result was $23.1 million, changed N/A from the prior year.
• Cash from Financing Activities for Q2 2025 stood at $3.2 million, up from -$1.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $34.4 million in Q3 2021, with the low at -$4.6 million in Q2 2023.
• Historically, Cash from Financing Activities has averaged $2.3 million across 5 years, with a median of -$95500.0 in 2023.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 1934.67% — and 2024, when it jumped 3509.33%.
• SRx Health Solutions' Cash from Financing Activities stood at -$552000.0 in 2021, then retreated by 1.63% to -$561000.0 in 2022, then soared by 41.53% to -$328000.0 in 2023, then plunged by 982.32% to -$3.6 million in 2024, then soared by 188.85% to $3.2 million in 2025.
• The last three Cash from Financing Activities figures came in at $3.2 million (Q2 2025), -$1.2 million (Q1 2025), and -$3.6 million (Q4 2024), per Business Quant data.